← Evidence map

ArticleEBioMedicine2020

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses.

Alice Gutjahr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32739871